| Literature DB >> 27191867 |
Robert J Arciuolo, Jennifer B Rosen, Jane R Zucker.
Abstract
Entities:
Keywords: Bordetella pertussis; New York; New York City; United States; bacteria; communicable disease control; disease notification; pertussis; surveillance; surveys; whooping cough
Mesh:
Year: 2016 PMID: 27191867 PMCID: PMC4880097 DOI: 10.3201/eid2206.151514
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Provider responses to survey questions related to diagnostic testing for pertussis, New York City, New York, USA*
| Questions and responses | No. (%) |
|---|---|
| Did respondent perform diagnostic tests for pertussis before 2012? | |
| Did not perform diagnostic tests | 282 (66) |
| Performed ≥1 diagnostic test | 147 (34) |
| Which types of diagnostic tests did respondent perform before 2012?† | |
| Bacterial culture | 68 (46) |
| PCR | 66 (45) |
| Serology | 35 (24) |
| DFA | 41 (28) |
| Did respondent change the types of diagnostic tests he/she performed since 2012?‡ | |
| Yes | 52 (12) |
| No | 269 (63) |
| Unknown | 108 (25) |
| Which types of diagnostic tests was respondent more likely to perform since 2012?§ | |
| Bacterial culture | 17 (33) |
| PCR | 33 (63) |
| Serology | 6 (12) |
| DFA | 5 (10) |
| No test | 3 (6) |
| Did respondent change the frequency of diagnostic tests he/she performed since 2012? | |
| More frequent testing | 93 (22) |
| Less frequent testing | 14 (3) |
| Frequency of testing unchanged | 231 (54) |
| No response provided | 1 (<1) |
*N = 429 except as indicated. DFA, direct fluorescent antibody test. †For 147 respondents who reported performing >1 diagnostic test before 2012. Response choices are not mutually exclusive. ‡For all respondents, including those who reported not performing diagnostic tests before 2012. §For 52 respondents who reported a change in type of diagnostic test performed since 2012. Response choices are not mutually exclusive.